Clinical Effect of Add-On Primovist-Enhanced Magnetic Resonance Imaging on Preoperative Tumor Staging in Hepatocellular Carcinoma Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jin, Young-Joo | - |
dc.contributor.author | Lee, Jin-Woo | - |
dc.contributor.author | Kwon, Oh Sang | - |
dc.contributor.author | Jung, Young Kul | - |
dc.contributor.author | Kwon, Jung Hyun | - |
dc.contributor.author | Jang, Jeong Won | - |
dc.contributor.author | Kim, Young Seok | - |
dc.contributor.author | Kim, Tae Hun | - |
dc.contributor.author | Jeon, Yong Sun | - |
dc.date.available | 2020-11-02T11:42:00Z | - |
dc.date.issued | 2016-07-01 | - |
dc.identifier.issn | 0022-4790 | - |
dc.identifier.issn | 1096-9098 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/6253 | - |
dc.description.abstract | Background/Aims: We analyzed the incidence of change of Barcelona Clinic Liver Cancer (BCLC) stage after add-on Primovist-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma (HCC) patients with Barcelona Clinic Liver Cancer stage 0 or A as determined by liver dynamic computed tomography (LDCT). Methods: Atotal of 166 patients enrolled prospectively between August 2012 and December 2014 were retrospectively analyzed. The rates of stage change after Primovist-enhanced MRI and the treatment finally adopted in patients with stage change were evaluated. Results: Of the 166 patients, 24 (18.6%) had truly new HCCs. Forty-six (27.7%) and 120 (72.3%) patients had BCLC stages 0 and A, respectively, before Primovist-enhanced MRI, but after Primovist-enhanced MRI, 28 (16.9%), 134 (80.7%), and 4 (2.4%) patients had BCLC stages 0, A, and B, respectively. Tumor stage changed in 22 (13.3%) patients, from 0 to A (18, 39.1%) or A to B (4, 3.3%). Conclusions: Add-on Primovist-enhanced magnetic resonance imaging can change BCLC stage with 13.3% in patients with BCLC 0 or A staged HCC, as determined by LDCT. (C) 2016 Wiley Periodicals, Inc. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.title | Clinical Effect of Add-On Primovist-Enhanced Magnetic Resonance Imaging on Preoperative Tumor Staging in Hepatocellular Carcinoma Patients | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1002/jso.24272 | - |
dc.identifier.wosid | 000383777600018 | - |
dc.identifier.bibliographicCitation | JOURNAL OF SURGICAL ONCOLOGY, v.114, no.1, pp 106 - 111 | - |
dc.citation.title | JOURNAL OF SURGICAL ONCOLOGY | - |
dc.citation.volume | 114 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 106 | - |
dc.citation.endPage | 111 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | DONOR LIVER-TRANSPLANTATION | - |
dc.subject.keywordPlus | DIFFUSION-WEIGHTED MRI | - |
dc.subject.keywordPlus | VIRUS-ENDEMIC AREA | - |
dc.subject.keywordPlus | INTRAHEPATIC RECURRENCE | - |
dc.subject.keywordPlus | MILAN CRITERIA | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | CIRRHOSIS | - |
dc.subject.keywordPlus | PATTERNS | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | primovist-enhanced magnetic resonance imaging | - |
dc.subject.keywordAuthor | Barcelona clinic liver cancer | - |
dc.subject.keywordAuthor | liver dynamic computed tomography | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.